|
|
Independent Laboratories
Resources/Letters
Letters
-
Revision of approval criterion for certain brand medically necessary
drugs, 11/1/04
Effective immediately, the Department of Health and Family Services
is revising one approval criterion for certain brand medically
necessary (BMN) narrow therapeutic index (NTI) drugs.
-
Notice to
Medicaid and BadgerCare Recipients and SeniorCare Participants, 9/1/04
Effective September 1, 2004, Wisconsin Medicaid and BadgerCare fee-for-service recipients
and all SeniorCare participants will be required to have prior
authorization for certain brand name drugs.
-
SSRI Letter —
Pharmacy Provider, 2/20/04
This letter includes important information regarding prior
authorization
for brand-name Selective Serotonin Re-uptake Inhibitors (SSRIs) — Effective March 15, 2004.
-
STAT-PA
Letter — Nonsedating Antihistamine Drugs, 11/12/03
This letter is regarding all nonsedating antihistamines except
over-the-counter Loratadine, effective after December 1, 2003.
Attached is the STAT PA-Drug Worksheet for Nonsedating Antihistamine Drugs.
-
Reimbursement Rate Change
Letter for Providers (PDF, 15 KB), 8/7/03
This letter is regarding reimbursement rate change for pharmacies, effective
August 15, 2003.
Other Resource Materials
Independent Laboratories Home
|